Literature DB >> 30337722

Trends in the global immuno-oncology landscape.

Jun Tang1, Laura Pearce1, Jill O'Donnell-Tormey1, Vanessa M Hubbard-Lucey1.   

Abstract

Mesh：

Year:  2018        PMID： 30337722     DOI： 10.1038/nrd.2018.167

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  36 in total

Review 1.  The Landscape of Early Clinical Gene Therapies outside of Oncology.

Authors:  Laure Rittié; Takis Athanasopoulos; Miguel Calero-Garcia; Marie L Davies; David J Dow; Steven J Howe; Alastair Morrison; Ida Ricciardelli; Aurore Saudemont; Laurent Jespers; Timothy M Clay
Journal:  Mol Ther       Date:  2019-09-06       Impact factor: 11.454

Review 2.  Industrializing engineered autologous T cells as medicines for solid tumours.

Authors:  Cedrik M Britten; Aiman Shalabi; Axel Hoos
Journal:  Nat Rev Drug Discov       Date:  2021-04-08       Impact factor: 84.694

Review 3.  Activation-induced cell death in CAR-T cell therapy.

Authors:  Tian Huan; Dongfeng Chen; Guodong Liu; Hailing Zhang; Xiaoyan Wang; Zhi Wu; Yan Wu; Qinggang Xu; Feng Yu
Journal:  Hum Cell       Date:  2022-01-15       Impact factor: 4.174

4.  CRISPR Screens to Identify Regulators of Tumor Immunity.

Authors:  Martin W LaFleur; Arlene H Sharpe
Journal:  Annu Rev Cancer Biol       Date:  2021-12-23

5.  CD73: an emerging checkpoint for cancer immunotherapy.

Authors:  Siqi Chen; Derek A Wainwright; Jennifer D Wu; Yong Wan; Daniela E Matei; Yi Zhang; Bin Zhang
Journal:  Immunotherapy       Date:  2019-06-21       Impact factor: 4.196

Review 6.  Repurposing Infectious Diseases Vaccines Against Cancer.

Authors:  Liese Vandeborne; Pan Pantziarka; An M T Van Nuffel; Gauthier Bouche
Journal:  Front Oncol       Date:  2021-05-13       Impact factor: 6.244

7.  Quantitative systems pharmacology modeling provides insight into inter-mouse variability of Anti-CTLA4 response.

Authors:  Wenlian Qiao; Lin Lin; Carissa Young; Jatin Narula; Fei Hua; Andrew Matteson; Andrea Hooper; Lore Gruenbaum; Alison Betts
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-05-08

Review 8.  Beyond immune checkpoint blockade: emerging immunological strategies.

Authors:  Shawn P Kubli; Thorsten Berger; Daniel V Araujo; Lillian L Siu; Tak W Mak
Journal:  Nat Rev Drug Discov       Date:  2021-03-08       Impact factor: 84.694

9.  Mathematical Modelling Based on In Vivo Imaging Suggests CD137-Stimulated Cytotoxic T Lymphocytes Exert Superior Tumour Control Due to an Enhanced Antimitotic Effect on Tumour Cells.

Authors:  Richard J Beck; Bettina Weigelin; Joost B Beltman
Journal:  Cancers (Basel)       Date:  2021-05-24       Impact factor: 6.639

Review 10.  Anti-PD-1 checkpoint blockade monotherapy in the orthotopic GL261 glioma model: the devil is in the detail.

Authors:  Zachariah P Tritz; Katayoun Ayasoufi; Aaron J Johnson
Journal:  Neurooncol Adv       Date:  2021-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.